Key result
Toll-like receptors drive ischaemia/reperfusion injury and muscle damage in critical limb ischaemia.
Toll-like receptors (TLRs) are key receptors of the innate immune system which are expressed on immune and nonimmune cells. They are activated by both pathogen-associated molecular patterns and endogenous ligands. Activation of TLRs culminates in the release of proinflammatory cytokines, chemokines, and apoptosis. Ischaemia and ischaemia/reperfusion (I/R) injury are associated with significant inflammation and tissue damage. There is emerging evidence to suggest that TLRs are involved in mediating ischaemia-induced damage in several organs. Critical limb ischaemia (CLI) is the most severe form of peripheral arterial disease (PAD) and is associated with skeletal muscle damage and tissue loss; however its pathophysiology is poorly understood. This paper will underline the evidence implicating TLRs in the pathophysiology of cerebral, renal, hepatic, myocardial, and skeletal muscle ischaemia and I/R injury and discuss preliminary data that alludes to the potential role of TLRs in the pathophysiology of skeletal muscle damage in CLI.
No takes yet. Share an insight, caveat, or question.
Patel et al. (2012) conducted a review in Critical limb ischaemia and ischaemia/reperfusion injury. Toll-like receptor activation was evaluated on Skeletal muscle and organ ischaemia/reperfusion damage. Toll-like receptors are implicated in mediating organ ischaemia/reperfusion injury and may play a role in skeletal muscle damage in critical limb ischaemia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: